| Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231) |
|---|
| 12/11/2012 | US8329399 Endometrial biomarkers |
| 12/11/2012 | US8329398 Universal amplification of fragmented RNA |
| 12/11/2012 | US8329397 Chemiluminescence proximity nucleic acid assay |
| 12/11/2012 | US8329396 Cloned DNA sequences hybridizable with genomic RNA of lymphadenopathy associated virus (LAV) |
| 12/11/2012 | US8329395 Thiamin production by fermentation |
| 12/11/2012 | US8329394 Methods and substances for isolation and detection of small polynucleotides |
| 12/11/2012 | US8329393 Method for detecting and removing endotoxin |
| 12/11/2012 | US8329392 Determination of testosterone by mass spectrometry |
| 12/11/2012 | US8329391 entail analysis of the pyro-glutamate (gyro-Glu) content of the glatiramer acetate in a sample; for multiple sclerosis |
| 12/11/2012 | US8329390 Detection of transmembrane potentials using N,N,N′-trialkyl thiobarbituric acid-derived polymethine oxonols |
| 12/11/2012 | US8329164 Methods and compositions concerning poxviruses and cancer |
| 12/11/2012 | US8329104 Measurement device with at least one sensor |
| 12/11/2012 | US8329026 Determination of blood glucose in a small volume and in a short test time using short read potentials |
| 12/11/2012 | US8329009 High throughput screening of ion channels |
| 12/11/2012 | US8328736 Tape transport lance sampler |
| 12/11/2012 | CA2656531C Protease screening methods and proteases identified thereby |
| 12/11/2012 | CA2501056C Methods and materials for using chemical compounds as a tool for nucleic acid storage on media of nucleic acid purification systems |
| 12/11/2012 | CA2495306C Water soluble metal and semiconductor nanoparticle complexes |
| 12/11/2012 | CA2481479C Novel flavivirus antigens |
| 12/11/2012 | CA2411563C Use of hydrogenotrophic acetogenic strains for preventing or treating digestive disorders |
| 12/11/2012 | CA2357037C Optical sorting method |
| 12/11/2012 | CA2349841C Corn event pv-zmgt32(nk603) and compositions and methods for detection thereof |
| 12/11/2012 | CA2332619C Characterisation of gene function using double stranded rna inhibition |
| 12/11/2012 | CA2324379C Anthrax lethal factor is a mapk kinase protease |
| 12/11/2012 | CA2202519C Cloning, expression and characterization of a new form of phosphatidylinositol-3-kinase |
| 12/06/2012 | WO2012167278A1 Molecular diagnostic test for cancer |
| 12/06/2012 | WO2012167221A1 Optofluidic tweezers |
| 12/06/2012 | WO2012167218A2 Device and method for identifying microbes and counting microbes and determining antimicrobial sensitivity |
| 12/06/2012 | WO2012167192A2 Methods and products for producing engineered mammalian cell lines with amplified transgenes |
| 12/06/2012 | WO2012167145A2 Genome-scale analysis of aberrant dna methylation in colorectal cancer |
| 12/06/2012 | WO2012167112A2 Gastric cancer biomarkers |
| 12/06/2012 | WO2012167086A2 Methods of diagnosing and treating amyotrophic lateral sclerosis |
| 12/06/2012 | WO2012167083A2 Method for measuring somatic dna mutational profiles |
| 12/06/2012 | WO2012167011A1 Dsrna/dna hybrid genome replication intermediate of metakaryotic stem cells |
| 12/06/2012 | WO2012166971A2 Method of assessing risk of pml |
| 12/06/2012 | WO2012166913A1 Rapid thermocycler system for rapid amplification of nucleic acids and related methods |
| 12/06/2012 | WO2012166899A2 Biomarkers for predicting and assessing responsiveness of thyroid and kidney cancer subjects to lenvatinib compounds |
| 12/06/2012 | WO2012166848A2 Methods and compositions for the detection of functional clostridium difficile toxins |
| 12/06/2012 | WO2012166824A2 Methods and kits that identify tumors responsive to src inhibitors |
| 12/06/2012 | WO2012166755A1 Enzyme-linked immunosorbent assay for quantitation of residual trypsin in a biological sample |
| 12/06/2012 | WO2012166742A2 Systems and methods for genetic and biological analysis |
| 12/06/2012 | WO2012166715A2 Compositions and methods for the detection of dna cleavage complexes |
| 12/06/2012 | WO2012166700A2 Molecular profiling of a lethal tumor microenvironment |
| 12/06/2012 | WO2012166647A1 Methods for manipulating biomolecules |
| 12/06/2012 | WO2012166630A2 In vitro test system to evaluate xenobiotics as immune-modulators of drug transport and metabolism in human hepatocytes |
| 12/06/2012 | WO2012166425A2 Methods of amplifying whole genome of a single cell |
| 12/06/2012 | WO2012166151A1 Use of dihydropyridophthalazinone inhibitors of poly (adp-ribose) polymerase (parp) in the treatment of myelodysplastic syndrome (mds) and acute myeloid leukaemia (aml) |
| 12/06/2012 | WO2012166056A1 Fragment-based approach for inhibitor design by amide hydrogen/deuterium exchange mass spectrometry |
| 12/06/2012 | WO2012165961A1 Pest resistant plants |
| 12/06/2012 | WO2012165943A1 A method of analysing a blood sample of a subject for the presence of an infectious disease marker |
| 12/06/2012 | WO2012165542A1 Mutant replicon derived from genome of hepatitis c virus j6cf strain |
| 12/06/2012 | WO2012165407A1 Method for screening for therapeutic agent for cartilage diseases, and genetically modified cartilage cell for use in treatment of cartilage diseases |
| 12/06/2012 | WO2012165287A1 Production method for artificial cancer stem cell and induced differentiation method therefor |
| 12/06/2012 | WO2012165036A1 Detection device and detection method |
| 12/06/2012 | WO2012164936A1 Suv39h2 as a target gene for cancer therapy and diagnosis |
| 12/06/2012 | WO2012164547A1 Kit and method of detecting the resistant microorganisms to a therapeutic agent |
| 12/06/2012 | WO2012164401A1 Assessment of cancer risk based on rnu2 cnv and interplay between rnu2 cnv and brca1 |
| 12/06/2012 | WO2012164136A1 TGF-β AND/OR SMAD3 AS MARKERS FOR THE DIAGNOSIS AND/OR PROGNOSIS OF α-SYNUCLEINOPATHIES |
| 12/06/2012 | WO2012163949A1 Torque teno virus diagnostics |
| 12/06/2012 | WO2012163941A2 Marker for the detection and classification of leukemia from blood samples |
| 12/06/2012 | WO2012163541A1 Methods and devices for prognosis of cancer relapse |
| 12/06/2012 | WO2012163389A1 Cichorium spp. male sterile mutants |
| 12/06/2012 | WO2012163263A1 Reagents and methods for prrsv detection |
| 12/06/2012 | WO2012163087A1 Method for sperm motility evaluation and screening and its microfluidic device |
| 12/06/2012 | WO2012162884A1 Kits, devices and methods for detecting chromosome copy number of embryo or tumor |
| 12/06/2012 | WO2012162812A1 Polymorphism panels predictive of anthracycline-induced cardiotoxicity (act) |
| 12/06/2012 | WO2012162779A1 Microfluidic cell trap and assay apparatus for high-throughput analysis |
| 12/06/2012 | WO2012162741A1 Enrichment of cardiomyocytes |
| 12/06/2012 | WO2012142349A3 Gene expression profile for therapeutic response to vegf inhibitors |
| 12/06/2012 | WO2012142159A3 Structural mutations in titin cause dilated cardiomyopathy |
| 12/06/2012 | WO2012138741A3 Bipolar flyback power supply |
| 12/06/2012 | WO2012129341A3 Disease detection in plants |
| 12/06/2012 | WO2012125781A3 Rapid detection of pathogens using paper devices |
| 12/06/2012 | WO2012125721A9 Methods and materials for using the contents of phagocytes to detect neoplasms |
| 12/06/2012 | WO2012118800A3 Enhancing endotoxin detection |
| 12/06/2012 | WO2012109617A3 Method of assaying dna topoisomerases and dna binding proteins using high throughput screening |
| 12/06/2012 | WO2012100027A3 Epigenetic biomarkers for liver disease |
| 12/06/2012 | WO2012099397A3 Method for determining the single nucleotide polymorphism of target genes using a real-time polymerase chain reaction, and kit for determining the single nucleotide polymorphism of target genes using same |
| 12/06/2012 | WO2012096523A3 Detection of target nucleic acid sequences by pto cleavage and extension assay |
| 12/06/2012 | WO2012094682A3 Materials and method for genotyping and quantifying a high-risk human papillomavirus |
| 12/06/2012 | WO2012092376A3 Comprehensive monoclonal antibody generation |
| 12/06/2012 | WO2012088348A3 Fetal genetic variation detection |
| 12/06/2012 | WO2012078792A3 Non-invasive determination of fetal inheritance of parental haplotypes at the genome-wide scale |
| 12/06/2012 | WO2012078602A3 Method for diagnosis and method of treatment of autism spectrum disorders and intellectual disability |
| 12/06/2012 | WO2012070037A3 Methods and materials for classification of tissue of origin of tumor samples |
| 12/06/2012 | WO2012003330A3 Multiplexed identification of nucleic acid sequences |
| 12/06/2012 | WO2011131360A8 Method of determining the metastatic potential of a tumor |
| 12/06/2012 | WO2009038536A8 A device, system and method for washing and isolating magnetic particles in a continuous fluid flow |
| 12/06/2012 | US20120311733 Lettuce variety 41-122 rz |
| 12/06/2012 | US20120311732 Lettuce variety 79-41 rz |
| 12/06/2012 | US20120311728 Methods and pharmaceutical composition for the treatment of atherosclerosis |
| 12/06/2012 | US20120310141 Light delivery device and related compositions, methods and systems |
| 12/06/2012 | US20120309953 Propargyl Substituted Nucleoside Compounds and Methods |
| 12/06/2012 | US20120309951 Oligonucleotide sequence formula for labeling oligonucleotide probes and proteins for in-situ analysis |
| 12/06/2012 | US20120309813 DELIVERY OF dsRNA TO ARTHROPODS |
| 12/06/2012 | US20120309704 Compositions for treatment of chemoresistant and/or potentially chemoresistant leukaemias |
| 12/06/2012 | US20120309700 Development and evaluation of novel chinese materia medica preparations |
| 12/06/2012 | US20120309690 Prostaglandin-f2 alpha receptor modulators and uses thereof |
| 12/06/2012 | US20120309671 Process for the measurement of the potency of glatiramer acetate |
| 12/06/2012 | US20120309645 miRNA IN THE DIAGNOSIS OF OVARIAN CANCER |